{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:58:23Z","timestamp":1775624303308,"version":"3.50.1"},"reference-count":61,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Karlheinz-Hartmann-Stiftung","award":["No Data"],"award-info":[{"award-number":["No Data"]}]},{"name":"Hilde-Ulrichs-Foundation, Frankfurt am Main, Germany","award":["No Data"],"award-info":[{"award-number":["No Data"]}]},{"name":"MHH plus Foundation","award":["No Data"],"award-info":[{"award-number":["No Data"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Diagnosis of atypical parkinsonian syndromes (APS), including progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), rely on clinical criteria that often result in misclassification or delayed confirmation. Cerebrospinal fluid (CSF) metabolomics offers the potential to identify disease-specific biochemical \u201cfingerprints\u201d. The aim of the study is to identify CSF metabolomic biomarkers that distinguish PSP and MSA from each other and from non-neurodegenerative controls. Targeted mass spectrometry-based metabolomics was performed on CSF samples from 30 patients with MSA, 41 with PSP, and 30 age- and sex-matched non-neurodegenerative controls. Global metabolomic profiles showed no clear group separation. Both PSP and MSA showed elevated gut-derived metabolites p-cresyl sulfate and deoxycholic acid versus controls. In PSP, decreased cortisone and increased hexosylceramide d18:1\/24:1 were observed, whereas in MSA, dihydroxyphenylalanine was elevated alongside homoarginine and creatinine. In the direct comparison of APS, levels of \u03b1-aminoadipic acid were increased in PSP compared to MSA. Pathway analysis highlighted disrupted glycerophospholipid metabolism in both APS disorders. Distinct metabolite panels mainly combining membrane-associated lipids, gut-derived and neurotransmitter-related metabolites demonstrated high diagnostic accuracy for distinguishing PSP and MSA from control groups (AUC = 0.95 for PSP and AUC = 0.98 for MSA), while a separate panel showed moderate performance in differentiating PSP from MSA (AUC = 0.85). Distinct but partially overlapping CSF metabolomic profiles characterize PSP and MSA. These metabolomic fingerprints highlight gut\u2013brain axis involvement, alterations in cell membrane-related lipid metabolism, and disease-specific changes in neurotransmitter-related metabolites. Further, a panel of these metabolites showed strong potential as diagnostic biomarkers.<\/jats:p>","DOI":"10.3390\/ijms27073270","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T02:06:21Z","timestamp":1775441181000},"page":"3270","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes"],"prefix":"10.3390","volume":"27","author":[{"given":"Lan","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Wegner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"},{"name":"Systems Neuroscience Hannover (ZSN), 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine J.","family":"Smandzich","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"},{"name":"Systems Neuroscience Hannover (ZSN), 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2397-7123","authenticated-orcid":false,"given":"Olivia","family":"Rudtke","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"},{"name":"Systems Neuroscience Hannover (ZSN), 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl Deniz","family":"Efe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-0121","authenticated-orcid":false,"given":"Matthias","family":"H\u00f6llerhage","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishana Viktoria","family":"Schneidereit","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Greten","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-9324","authenticated-orcid":false,"given":"Sven","family":"Schuchardt","sequence":"additional","affiliation":[{"name":"Department of Bio- and Environmental Analytics, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3054-9905","authenticated-orcid":false,"given":"Martin","family":"Klietz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School, Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The Phenotypic Spectrum of Progressive Supranuclear Palsy: A Retrospective Multicenter Study of 100 Definite Cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria","volume":"32","author":"Respondek","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second Consensus Statement on the Diagnosis of Multiple System Atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/npjparkd.2015.7","article-title":"Comparison of Clinical Features in Pathologically Confirmed PSP and MSA Patients Followed at a Tertiary Center","volume":"1","author":"Xie","year":"2015","journal-title":"npj Park. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low Clinical Diagnostic Accuracy of Early vs. Advanced Parkinson Disease: Clinicopathologic Study","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","article-title":"Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome","volume":"77","author":"Jabbari","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s Disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: Beyond Biomarkers and towards Mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1007\/s00415-020-09824-1","article-title":"Metabolomic Changes Associated with Frontotemporal Lobar Degeneration Syndromes","volume":"267","author":"Murley","year":"2020","journal-title":"J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mori, A., Ishikawa, K.-I., Saiki, S., Hatano, T., Oji, Y., Okuzumi, A., Fujimaki, M., Koinuma, T., Ueno, S.-I., and Imamichi, Y. (2019). Plasma Metabolite Biomarkers for Multiple System Atrophy and Progressive Supranuclear Palsy. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223113"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pathan, M., Wu, J., Lakso, H.-\u00c5., Forsgren, L., and \u00d6hman, A. (2021). Plasma Metabolite Markers of Parkinson\u2019s Disease and Atypical Parkinsonism. Metabolites, 11.","DOI":"10.3390\/metabo11120860"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"George, N.P., Kwon, M., Jang, Y.E., Kim, S.G., Hwang, J.S., Lee, S.S., and Lee, G. (2025). Integrative Analysis of Metabolome and Proteome in the Cerebrospinal Fluid of Patients with Multiple System Atrophy. Cells, 14.","DOI":"10.3390\/cells14040265"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-024-47971-5","article-title":"Cerebrospinal Fluid Reference Proteins Increase Accuracy and Interpretability of Biomarkers for Brain Diseases","volume":"15","author":"Karlsson","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","article-title":"Evolving Concepts in Progressive Supranuclear Palsy and Other 4-Repeat Tauopathies","volume":"17","author":"Stamelou","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathmechdis-051122-104528","article-title":"Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward","volume":"20","author":"Ndayisaba","year":"2025","journal-title":"Annu. Rev. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sun, C.-Y., Li, J.-R., Wang, Y.-Y., Lin, S.-Y., Ou, Y.-C., Lin, C.-J., Wang, J.-D., Liao, S.-L., and Chen, C.-J. (2020). P-Cresol Sulfate Caused Behavior Disorders and Neurodegeneration in Mice with Unilateral Nephrectomy Involving Oxidative Stress and Neuroinflammation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186687"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13024-023-00694-5","article-title":"Untargeted Serum Metabolomics Reveals Novel Metabolite Associations and Disruptions in Amino Acid and Lipid Metabolism in Parkinson\u2019s Disease","volume":"18","author":"Paul","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2019.10.038","article-title":"Higher Cerebrospinal Fluid to Plasma Ratio of P-Cresol Sulfate and Indoxyl Sulfate in Patients with Parkinson\u2019s Disease","volume":"501","author":"Sankowski","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Willkommen, D., Lucio, M., Moritz, F., Forcisi, S., Kanawati, B., Smirnov, K.S., Schroeter, M., Sigaroudi, A., Schmitt-Kopplin, P., and Michalke, B. (2018). Metabolomic Investigations in Cerebrospinal Fluid of Parkinson\u2019s Disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208752"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41531-025-01040-w","article-title":"Enrichment of Gut-Derived Metabolites in a Parkinson\u2019s Disease Subtype with REM Sleep Behavior Disorder","volume":"11","author":"Lee","year":"2025","journal-title":"npj Park. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling Gut Microbiota in Parkinson\u2019s Disease and Atypical Parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The Microbiome-Gut-Brain Axis in Parkinson Disease\u2014From Basic Research to the Clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/asj\/sjae198","article-title":"Peripheral Nerve Injury After Deoxycholic Acid (ATX-101) Injection in an Experimental Rat Model","volume":"45","author":"Chi","year":"2025","journal-title":"Aesthet. Surg. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbalip.2004.12.008","article-title":"Regulatory Enzymes of Phosphatidylcholine Biosynthesis: A Personal Perspective","volume":"1733","author":"Kent","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_26","first-page":"29","article-title":"Phosphatidylethanolamine Metabolism in Health and Disease","volume":"321","author":"Calzada","year":"2015","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"117443","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The Mechanisms of Lysophosphatidylcholine in the Development of Diseases","volume":"247","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Farooqui, A. (2009). Apoptosis and Necrosis in Brain: Contribution of Glycerophospholipid, Sphingolipid, and Cholesterol-Derived Lipid Mediators. Hot Topics in Neural Membrane Lipidology, Springer.","DOI":"10.1007\/978-0-387-09693-3_10"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1038\/s41467-024-50299-9","article-title":"Spatially and Temporally Probing Distinctive Glycerophospholipid Alterations in Alzheimer\u2019s Disease Mouse Brain via High-Resolution Ion Mobility-Enabled Sn-Position Resolved Lipidomics","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13024-025-00876-3","article-title":"Glycerophospholipids in ALS: Insights into Disease Mechanisms and Clinical Implication","volume":"20","author":"Burg","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1073\/pnas.1402663111","article-title":"Effect of Sleep Deprivation on the Human Metabolome","volume":"111","author":"Davies","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41380-020-0744-2","article-title":"The Gut Microbiome Modulates Gut-Brain Axis Glycerophospholipid Metabolism in a Region-Specific Manner in a Nonhuman Primate Model of Depression","volume":"26","author":"Zheng","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jnc.15133","article-title":"The Role of Sphingolipids in Myelination and Myelin Stability and Their Involvement in Childhood and Adult Demyelinating Disorders","volume":"156","author":"Giussani","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive Supranuclear Palsy: Pathology and Genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jnr.490170312","article-title":"Comparisons of Proteins and Glycoproteins in Neuronal Plasma Membranes, Axolemma, Synaptic Membranes, and Oligodendroglial Plasma Membranes","volume":"17","author":"Hampson","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"McCann, M.R., George De la Rosa, M.V., Rosania, G.R., and Stringer, K.A. (2021). L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine. Metabolites, 11.","DOI":"10.3390\/metabo11010051"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17083","DOI":"10.1038\/s41598-023-41628-x","article-title":"\u03b3-Aminobutyric Acids (GABA) and Serum GABA\/AABA (G\/A) Ratio as Potential Biomarkers of Physical Performance and Aging","volume":"13","author":"Lyssikatos","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/jnr.23072","article-title":"Valine but Not Leucine or Isoleucine Supports Neurotransmitter Glutamate Synthesis during Synaptic Activity in Cultured Cerebellar Neurons","volume":"90","author":"Bak","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yfrne.2008.11.002","article-title":"Neurobiological and Neuropsychiatric Effects of Dehydroepiandrosterone (DHEA) and DHEA Sulfate (DHEAS)","volume":"30","author":"Maninger","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Vitku, J., Hill, M., Kolatorova, L., Kubala Havrdova, E., and Kancheva, R. (2022). Steroid Sulfation in Neurodegenerative Diseases. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.839887"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12576-016-0442-7","article-title":"GABA and Glycine in the Developing Brain","volume":"66","author":"Ito","year":"2016","journal-title":"J. Physiol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2024-0005","article-title":"Glycine and Clozapine: Potential Relevance for the Treatment of Parkinson\u2019s Disease","volume":"14","author":"Maddaford","year":"2024","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kaleck\u00fd, K., Ashcraft, P., and Bottiglieri, T. (2022). One-Carbon Metabolism in Alzheimer\u2019s Disease and Parkinson\u2019s Disease Brain Tissue. Nutrients, 14.","DOI":"10.3390\/nu14030599"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e40593","DOI":"10.7554\/eLife.40593","article-title":"Sleep-Promoting Effects of Threonine Link Amino Acid Metabolism in Neuron to GABAergic Control of Sleep Drive","volume":"8","author":"Ki","year":"2019","journal-title":"Elife"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2019.10.025","article-title":"Creatinine: From Physiology to Clinical Application","volume":"72","author":"Kashani","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Jensen, M., M\u00fcller, C., Schwedhelm, E., Arunachalam, P., Gelderblom, M., Magnus, T., Gerloff, C., Zeller, T., and Choe, C.-U. (2020). Homoarginine- and Creatine-Dependent Gene Regulation in Murine Brains with L-Arginine:Glycine Amidinotransferase Deficiency. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051865"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/STROKEAHA.110.603035","article-title":"Low Serum Homoarginine Is a Novel Risk Factor for Fatal Strokes in Patients Undergoing Coronary Angiography","volume":"42","author":"Pilz","year":"2011","journal-title":"Stroke"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.acc.2019.07.009","article-title":"Metabolomics in Genetic Testing","volume":"Volume 94","author":"Troisi","year":"2020","journal-title":"Advances in Clinical Chemistry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2015.03.051","article-title":"NMR Metabonomics of Cerebrospinal Fluid Distinguishes between Parkinson\u2019s Disease and Controls","volume":"594","author":"Forsgren","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"149625","DOI":"10.1016\/j.brainres.2025.149625","article-title":"Plasma and Urinary Metabolomic Signatures Differentiate Genetic and Idiopathic Parkinson\u2019s Disease","volume":"1858","author":"Cotrin","year":"2025","journal-title":"Brain Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Forero-Rodr\u00edguez, L.J., Josephs-Spaulding, J., Flor, S., Pinz\u00f3n, A., and Kaleta, C. (2021). Parkinson\u2019s Disease and the Metal-Microbiome-Gut-Brain Axis: A Systems Toxicology Approach. Antioxidants, 11.","DOI":"10.3390\/antiox11010071"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/aws055","article-title":"Cerebrospinal Fluid Biomarkers of Central Catecholamine Deficiency in Parkinson\u2019s Disease and Other Synucleinopathies","volume":"135","author":"Goldstein","year":"2012","journal-title":"Brain"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00415-024-12207-5","article-title":"The Comorbidity Profiles and Medication Issues of Patients with Multiple System Atrophy: A Systematic Cross-Sectional Analysis","volume":"271","author":"Ye","year":"2024","journal-title":"J. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00415-023-12006-4","article-title":"The Comorbidity and Co-Medication Profile of Patients with Progressive Supranuclear Palsy","volume":"271","author":"Greten","year":"2024","journal-title":"J. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ye, L., Sani, S.S., Veith Sanches, L., Krey, L.F.M., Wegner, F., H\u00f6llerhage, M., Schrader, C., H\u00f6glinger, G., and Klietz, M. (2024). Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses. Brain Sci., 14.","DOI":"10.3390\/brainsci14100991"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s007020050016","article-title":"L-Glutamate, L-Arginine and L-Citrulline Levels in Cerebrospinal Fluid of Parkinson\u2019s Disease, Multiple System Atrophy, and Alzheimer\u2019s Disease Patients","volume":"107","author":"Kuiper","year":"2000","journal-title":"J. Neural Transm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/mds.21846","article-title":"Polyunsaturated Fatty Acid Levels in the Cerebrospinal Fluid of Patients with Parkinson\u2019s Disease and Multiple System Atrophy","volume":"23","author":"Lee","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1007\/s00415-024-12632-6","article-title":"Pharmacotherapy of Motor Symptoms in Early and Mid-Stage Parkinson\u2019s Disease: Guideline \u201cParkinson\u2019s Disease\u201d of the German Society of Neurology","volume":"271","author":"Becktepe","year":"2024","journal-title":"J. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5334\/ojb.70","article-title":"The Hannover Unified Biobank (HUB)\u2014Centralized Standardised Biobanking at Hannover Medical School","volume":"8","author":"Kopfnagel","year":"2021","journal-title":"Open J. Bioresour."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1007\/s00415-024-12667-9","article-title":"Metabolomic Profile of Cerebrospinal Fluid from Patients with Diffuse Gliomas","volume":"271","author":"Hounchonou","year":"2024","journal-title":"J. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: Towards a Unified Platform for Metabolomics Data Processing, Analysis and Interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3270\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:15:39Z","timestamp":1775621739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":61,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27073270"],"URL":"https:\/\/doi.org\/10.3390\/ijms27073270","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}